Oncology (Williston Park, N.Y.)最新文献_第9页

Inoperable primary renal cancer--stereotactic radiosurgery viable choice. 不能手术的原发性肾癌——立体定向放射手术可行的选择。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

引用次数: 0

Richter's syndrome: CLL taking a turn for the worse. 里希特氏综合症:CLL病情恶化。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Peter Hillmen

引用次数: 0

A new look at an old syndrome. 对老病的新认识。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

James O Armitage

引用次数: 0

Ethics of cost containment for cancer therapies: will the Affordable Care Act bring down costs? 癌症治疗成本控制的伦理:《平价医疗法案》会降低成本吗?

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Arthur Caplan

引用次数: 0

Reflections on my visit to a Chinese medical school--and an unplanned side trip to a Chinese hospital. 我访问一所中国医学院的感想——以及一次意外的中国医院之旅。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Paul R Helft

引用次数: 0

Palliative care for oncology patients. 肿瘤患者的姑息治疗。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Thomas J Smith

引用次数: 0

Clinicopathologic indices can improve patient selection in malignant mesothelioma. 临床病理指标可改善恶性间皮瘤患者的选择。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

David J Sugarbaker

引用次数: 0

Clinical and pathological features are still the best determinants of prognosis in mesothelioma. 临床和病理特征仍然是间皮瘤预后的最佳决定因素。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Andrew C Miller, Raffit Hassan

引用次数: 0

Seven charts, seven lives. 七张图表，七条命。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Craig R Hildreth

引用次数: 0

Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks. 早期霍奇金淋巴瘤的综合治疗:保持高治愈率同时降低风险。

Oncology (Williston Park, N.Y.) Pub Date : 2012-12-01

Chris R Kelsey, Anne W Beaven, Louis F Diehl, Leonard R Prosnitz

{"title":"Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks.","authors":"Chris R Kelsey, Anne W Beaven, Louis F Diehl, Leonard R Prosnitz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Multiple randomized studies have demonstrated that chemotherapy, most commonly ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, dacarbazine), followed by consolidation radiation therapy is the most effective treatment program for early-stage Hodgkin lymphoma. With a combined-modality approach, the great majority of patients are cured of their disease. It is also apparent that both chemotherapy and radiation therapy can increase the risk of complications in the decades following treatment, with second cancers and cardiac disease being the most common. Most studies,evaluating such risks primarily include patients treated in decades past with what are now considered outdated approaches, including high-dose, wide-field radiation therapy. The treatment of Hodgkin lymphoma has evolved significantly, particularly in regard to radiation therapy. In combination with chemotherapy, much lower doses and smaller fields are employed, with success equivalent to that achieved using older methods. Many studies have shown a significant decline in both the rates of second cancers and the risk of cardiac disease with low-dose radiation confined to the original extent of disease. In favorable patients, as few as 2 cycles of ABVD have been shown to be effective. The current combined-modality approach seeks to maintain high cure rates but minimize risks by optimizing both chemotherapy and radiation therapy</p>","PeriodicalId":520728,"journal":{"name":"Oncology (Williston Park, N.Y.)","volume":" ","pages":"1182-9, 1193"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31242970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0